These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15380203)

  • 1. Development of a polyvalent assay system for lead identification.
    Lovering F; Angell Y; Zhang YL; Bridges K
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5081-3. PubMed ID: 15380203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics.
    Combs AP; Yue EW; Bower M; Ala PJ; Wayland B; Douty B; Takvorian A; Polam P; Wasserman Z; Zhu W; Crawley ML; Pruitt J; Sparks R; Glass B; Modi D; McLaughlin E; Bostrom L; Li M; Galya L; Blom K; Hillman M; Gonneville L; Reid BG; Wei M; Becker-Pasha M; Klabe R; Huber R; Li Y; Hollis G; Burn TC; Wynn R; Liu P; Metcalf B
    J Med Chem; 2005 Oct; 48(21):6544-8. PubMed ID: 16220970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphoryltyrosyl mimetics in the design of peptide-based signal transduction inhibitors.
    Burke TR; Yao ZJ; Liu DG; Voigt J; Gao Y
    Biopolymers; 2001; 60(1):32-44. PubMed ID: 11376431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a new phosphotyrosine mimetic for PTP1B using breakaway tethering.
    Erlanson DA; McDowell RS; He MM; Randal M; Simmons RL; Kung J; Waight A; Hansen SK
    J Am Chem Soc; 2003 May; 125(19):5602-3. PubMed ID: 12733877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent benzimidazole sulfonamide protein tyrosine phosphatase 1B inhibitors containing the heterocyclic (S)-isothiazolidinone phosphotyrosine mimetic.
    Combs AP; Zhu W; Crawley ML; Glass B; Polam P; Sparks RB; Modi D; Takvorian A; McLaughlin E; Yue EW; Wasserman Z; Bower M; Wei M; Rupar M; Ala PJ; Reid BM; Ellis D; Gonneville L; Emm T; Taylor N; Yeleswaram S; Li Y; Wynn R; Burn TC; Hollis G; Liu PC; Metcalf B
    J Med Chem; 2006 Jun; 49(13):3774-89. PubMed ID: 16789735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isothiazolidinone heterocycles as inhibitors of protein tyrosine phosphatases: synthesis and structure-activity relationships of a peptide scaffold.
    Yue EW; Wayland B; Douty B; Crawley ML; McLaughlin E; Takvorian A; Wasserman Z; Bower MJ; Wei M; Li Y; Ala PJ; Gonneville L; Wynn R; Burn TC; Liu PC; Combs AP
    Bioorg Med Chem; 2006 Sep; 14(17):5833-49. PubMed ID: 16769216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based optimization of protein tyrosine phosphatase 1B inhibitors: from the active site to the second phosphotyrosine binding site.
    Wilson DP; Wan ZK; Xu WX; Kirincich SJ; Follows BC; Joseph-McCarthy D; Foreman K; Moretto A; Wu J; Zhu M; Binnun E; Zhang YL; Tam M; Erbe DV; Tobin J; Xu X; Leung L; Shilling A; Tam SY; Mansour TS; Lee J
    J Med Chem; 2007 Sep; 50(19):4681-98. PubMed ID: 17705360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly sensitive peptide-based probes for protein tyrosine phosphatase activity utilizing a fluorogenic mimic of phosphotyrosine.
    Mitra S; Barrios AM
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5142-5. PubMed ID: 16203147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6,8-Difluoro-4-methylumbiliferyl phosphate: a fluorogenic substrate for protein tyrosine phosphatases.
    Welte S; Baringhaus KH; Schmider W; Müller G; Petry S; Tennagels N
    Anal Biochem; 2005 Mar; 338(1):32-8. PubMed ID: 15707933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragment-based lead discovery using X-ray crystallography.
    Hartshorn MJ; Murray CW; Cleasby A; Frederickson M; Tickle IJ; Jhoti H
    J Med Chem; 2005 Jan; 48(2):403-13. PubMed ID: 15658854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotinylation and characterization of Cryptococcus neoformans cell surface proteins.
    Foster AJ; Bird RA; Smith SN
    J Appl Microbiol; 2007 Aug; 103(2):390-9. PubMed ID: 17650199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design of protein tyrosine phosphatase-1B inhibitors.
    Black E; Breed J; Breeze AL; Embrey K; Garcia R; Gero TW; Godfrey L; Kenny PW; Morley AD; Minshull CA; Pannifer AD; Read J; Rees A; Russell DJ; Toader D; Tucker J
    Bioorg Med Chem Lett; 2005 May; 15(10):2503-7. PubMed ID: 15863305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and biological evaluation of linear and cyclic phosphopeptide ligands of the N-terminal SH2 domain of protein tyrosine phosphatase SHP-1.
    Imhof D; Wieligmann K; Hampel K; Nothmann D; Zoda MS; Schmidt-Arras D; Zacharias M; Böhmer FD; Reissmann S
    J Med Chem; 2005 Mar; 48(5):1528-39. PubMed ID: 15743195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multilayer fluorescence optically encoded beads for protein detection.
    Jun BH; Rho C; Byun JW; Kim JH; Chung WJ; Kang H; Park J; Cho SH; Kim BG; Lee YS
    Anal Biochem; 2010 Jan; 396(2):313-5. PubMed ID: 19766091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based optimization of benzoic acids as inhibitors of protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase.
    Maccari R; Ottanà R; Ciurleo R; Paoli P; Manao G; Camici G; Laggner C; Langer T
    ChemMedChem; 2009 Jun; 4(6):957-62. PubMed ID: 19288492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A TAT-streptavidin fusion protein directs uptake of biotinylated cargo into mammalian cells.
    Albarran B; To R; Stayton PS
    Protein Eng Des Sel; 2005 Mar; 18(3):147-52. PubMed ID: 15820981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying selective protein tyrosine phosphatase substrates and inhibitors from a fluorogenic, combinatorial peptide library.
    Mitra S; Barrios AM
    Chembiochem; 2008 May; 9(8):1216-9. PubMed ID: 18412190
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibitors of protein tyrosine phosphatases: next-generation drugs?
    Bialy L; Waldmann H
    Angew Chem Int Ed Engl; 2005 Jun; 44(25):3814-39. PubMed ID: 15900534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of new potent human protein tyrosine phosphatase inhibitors via pharmacophore and QSAR analysis followed by in silico screening.
    Taha MO; Bustanji Y; Al-Bakri AG; Yousef AM; Zalloum WA; Al-Masri IM; Atallah N
    J Mol Graph Model; 2007 Mar; 25(6):870-84. PubMed ID: 17035054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular dynamics simulations of interaction between protein-tyrosine phosphatase 1B and a bidentate inhibitor.
    Liu GX; Tan JZ; Niu CY; Shen JH; Luo XM; Shen X; Chen KX; Jiang HL
    Acta Pharmacol Sin; 2006 Jan; 27(1):100-10. PubMed ID: 16364216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.